Ignite Creation Date:
2024-05-06 @ 3:18 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04582175
Status:
COMPLETED
Last Update Posted:
2020-10-09
First Post:
2020-10-04
Brief Title:
Comparison Between Two Revascularization Strategies in MVD Patients With Uncomplicated ST-elevation MI
Sponsor:
University of Oradea
Organization:
University of Oradea
Study Overview
Official Title:
A Retrospective One Center Comparison of Outcomes Between Complete Revascularization by PCI at the Time of PPCI or During the Index Hospital Admission in One Hundred MVD Patients With ST-elevation MI Uncomplicated by Cardiogenic Shock
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Promise
Brief Summary:
The study aimed to compare major adverse cardiac and cerebrovascular eventsMACCE and mortality at one year between two strategies complete revascularization including non-culprit lesions percutaneous coronary interventionPCI during primary PCIPPCI versus complete revascularisation during the same hospital admission in multi-vascular coronary artery diseaseMVD patients presenting with ST-elevation myocardial infarctionSTEMI uncomplicated by cardiogenic shock
Detailed Description:
Complete revascularisation in MVD patients with STEMI uncomplicated by cardiogenic shock has been shown to improve outcomes however the optimal timing of treatment of the non-culprit lesions is not known The 2018 ESCEACTS Guidelines on myocardial revascularization states that routine revascularization of non-IRA infarct related artery lesions should be considered in patients with multivessel disease before hospital discharge Our trial showed that among the fore mentioned patients there was no difference regarding outcomes when using a strategy of complete revascularization with non-culprit lesions PCI during PPCI or during the same hospital admission
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None